A single dose of zoledronate preserves bone mineral density for up to 2  years after a second course of romosozumab

ConclusionA zoledronate follow-on regimen can maintain robust BMD gains achieved with romosozumab treatment.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research